Blood transfusion risk: protecting against the unknown
- PMID: 9529394
- PMCID: PMC1112719
- DOI: 10.1136/bmj.316.7133.717
Blood transfusion risk: protecting against the unknown
Comment in
-
Recombinant factor VIII may not abolish risk of new variant CJD from factor VIII.BMJ. 1998 May 2;316(7141):1385. doi: 10.1136/bmj.316.7141.1385. BMJ. 1998. PMID: 9564003 Free PMC article. No abstract available.
-
Who should be liable for funding recombinant factor VIII?BMJ. 1998 May 2;316(7141):1385-6. doi: 10.1136/bmj.316.7141.1385a. BMJ. 1998. PMID: 9564004 Free PMC article. No abstract available.
Comment on
-
UK blood products are banned.BMJ. 1998 Mar 7;316(7133):726. doi: 10.1136/bmj.316.7133.723g. BMJ. 1998. PMID: 9529404 No abstract available.
References
-
- Report of a WHO consultation on medicinal and other products in relation to human and animal transmissible spongiform encephalopathies. Geneva: WHO, 1997 (WHO/EMC/ZOO/97.3).
-
- Hill AF, Zeidler M, Ironside J, Collinge J. Diagnosis of new variant Creutzfeldt-Jacob disease by tonsil biopsy. Lancet. 1997;349:99–100. - PubMed
-
- Royal College of Physicians of Edinburgh/Royal College of Obstetricians and Gynaecologists. Consensus conference April 1997. Transfusion Medicine. 1997;7:143–144. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical